Syneos Health [SYENS] vs Tessenderlo Group NV [TESB] Detailed Stock Comparison

Syneos Health, Inc.

EURONEXT
Loading...

Tessenderlo Group NV

EURONEXT
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Syneos Health, Inc. wins in 12 metrics, Tessenderlo Group NV wins in 7 metrics, with 0 ties. Syneos Health, Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Syneos Health, Inc. Tessenderlo Group NV Better
P/E Ratio (TTM) 377.86 37.21 Tessenderlo Group NV
Price-to-Book Ratio 0.94 0.74 Tessenderlo Group NV
Debt-to-Equity Ratio 48.61 11.70 Tessenderlo Group NV
PEG Ratio 28.45 10.63 Tessenderlo Group NV
EV/EBITDA 6.44 4.79 Tessenderlo Group NV
Profit Margin (TTM) -1.04% -2.94% Syneos Health, Inc.
Operating Margin (TTM) 4.55% 0.85% Syneos Health, Inc.
EBITDA Margin (TTM) 4.55% 0.85% Syneos Health, Inc.
Return on Equity -1.25% -4.43% Syneos Health, Inc.
Return on Assets (TTM) 2.60% 1.39% Syneos Health, Inc.
Free Cash Flow (TTM) $243.00M $74.30M Syneos Health, Inc.
Dividend Yield N/A 2.92% N/A
1-Year Return -0.44% -18.37% Syneos Health, Inc.
Price-to-Sales Ratio (TTM) 0.96 0.46 Tessenderlo Group NV
Enterprise Value $7.75B $1.30B Syneos Health, Inc.
EV/Revenue Ratio 1.30 0.47 Tessenderlo Group NV
Gross Profit Margin (TTM) 27.96% 17.68% Syneos Health, Inc.
Revenue per Share (TTM) $58 $46 Syneos Health, Inc.
Earnings per Share (Diluted) $-0.85 $-1.34 Syneos Health, Inc.
Beta (Stock Volatility) 0.13 0.57 Syneos Health, Inc.

Syneos Health, Inc. vs Tessenderlo Group NV Stock Performance Analysis

Loading Price Chart...

SYENS
TESB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Syneos Health, Inc.-2.45%0.15%19.51%32.95%-1.05%-3.18%
Tessenderlo Group NV-6.38%-3.52%-2.61%-18.93%-24.45%-21.56%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Syneos Health, Inc.-0.44%-28.89%-28.89%-28.89%-28.89%-28.89%
Tessenderlo Group NV-18.37%-25.17%-38.20%-30.56%-0.45%-0.45%

Performance & Financial Health Analysis: Syneos Health, Inc. vs Tessenderlo Group NV

MetricSYENSTESB
Market Information
Market Cap i€5.71B€1.26B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i144,35011,531
90 Day Avg. Volume i239,44423,194
Last Close€67.70€20.55
52 Week Range€41.76 - €82.12€19.36 - €28.75
% from 52W High-17.56%-28.52%
All-Time High€109.90 (Dec 11, 2023)€41.90 (Oct 30, 2017)
% from All-Time High-38.40%-50.95%
Growth Metrics
Quarterly Revenue Growth-0.17%0.01%
Quarterly Earnings Growth-0.17%-0.31%
Financial Health
Profit Margin (TTM) i-0.01%-0.03%
Operating Margin (TTM) i0.05%0.01%
Return on Equity (TTM) i-0.01%-0.04%
Debt to Equity (MRQ) i48.6111.70
Cash & Liquidity
Book Value per Share (MRQ)€59.38€28.65
Cash per Share (MRQ)€9.34€2.68
Operating Cash Flow (TTM) i€779.00M€225.70M
Levered Free Cash Flow (TTM) i€449.38M€121.28M
Dividends
Last 12-Month Dividend Yield iN/A2.92%
Last 12-Month Dividend iN/A€0.75

Valuation & Enterprise Metrics Analysis: Syneos Health, Inc. vs Tessenderlo Group NV

MetricSYENS (Apr 24, 2026)TESB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i377.8637.21
Forward P/E i13.1010.63
PEG Ratio i28.4510.63
Price to Sales (TTM) i0.960.46
Price to Book (MRQ) i0.940.74
Market Capitalization
Market Capitalization i€5.71B€1.26B
Enterprise Value i€7.75B€1.30B
Enterprise Value Metrics
Enterprise to Revenue i1.300.47
Enterprise to EBITDA i6.444.79
Risk & Other Metrics
Beta i0.130.57
Book Value per Share (MRQ) i€59.38€28.65

Financial Statements Comparison: Syneos Health, Inc. vs Tessenderlo Group NV

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSYENS (2025)TESB (2025)
Revenue/Sales i5.97B2.76B
Cost of Goods Sold i4.12B2.24B
COGS % of Revenue i69.1%81.0%
Gross Profit i1.85B525.70M
Gross Margin i30.9%19.0%
Research & Development i295.00M27.30M
Operating Income (EBIT) i512.00M66.20M
Operating Margin i8.6%2.4%
EBITDA i1.23B230.50M
EBITDA Margin i20.5%8.3%
Pre-Tax Income i42.00M-57.30M
Pre-Tax Income % of Revenue i0.7%-2.1%
Income Tax i127.00M22.90M
Income Tax % of Revenue i2.1%0.8%
Net Income (Profit) i-60.00M-80.20M
Profit Margin i-1.0%-2.9%

Balance Sheet & Liquidity Metrics

MetricSYENS (2025)TESB (2025)
Cash & Equivalents i861.00M158.00M
Total Current Assets i3.30B1.15B
Total Current Assets % of Revenue i55.2%41.6%
Total Current Liabilities i1.57B550.70M
Total Current Liabilities % of Revenue i26.4%19.9%
Long-Term Debt i2.86B107.20M
Long-Term Debt % of Revenue i47.9%3.9%
Total Shareholders Equity i6.09B1.70B
Retained Earnings i4.50BN/A
Retained Earnings % of Revenue i75.3%0.0%
Property, Plant & Equipment i376.00M762.30M

Cash Flow Statement Comparison

MetricSYENS (2025)TESB (2025)
Operating Cash Flow i149.00M-74.00M
Operating Cash Flow % of Revenue i2.5%-2.7%
Capital Expenditures i-427.00M-130.10M
Free Cash Flow i243.00M74.30M
FCF Margin i4.1%2.7%
Debt Repayment i-678.00M-181.20M
Common Stock Repurchase iN/A-37.00M

Short Interest & Institutional Ownership Analysis

MetricSYENSTESB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i101.95M58.99M
Float Shares i69.17M18.43M
% Held by Insiders i31.39%68.68%
% Held by Institutions i35.17%6.15%
% Held by Public i33.44%25.17%

Dividend Analysis & Yield Comparison: Syneos Health, Inc. vs Tessenderlo Group NV

MetricSYENSTESB
Last 12-Month Dividend iN/A€0.75
Last 12-Month Dividend Yield iN/A2.92%
3-Year Avg Annual Dividend iN/A€0.75
3-Year Avg Dividend Yield iN/A2.85%
3-Year Total Dividends iN/A€2.25
Ex-Dividend DateN/AJun 04, 2025